# Liposomal Bupivacaine Versus Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Total Knee Arthroplasty

> **NCT02624856** · PHASE4 · WITHDRAWN · sponsor: **Albany Medical College**

## Conditions studied

- Osteoarthritis
- Pain, Postoperative

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine plus dexamethasone

## Key facts

- **NCT ID:** NCT02624856
- **Lead sponsor:** Albany Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2020-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624856, "Liposomal Bupivacaine Versus Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02624856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*